Think Globally


Read Article
  • Current and Emerging Glaucoma Therapy

    An Update on Disease-Modifying Glaucoma Treatments

    Read Article


Visit @GlaucomaToday on Twitter

Articles From This Issue


Think Globally

COVER FOCUS Telemedicine and Technology

The worldwide prevalence of glaucoma in people aged 40 to 80 years is estimated to be 3.54%, disproportionally affecting individuals located in Asia and Africa.1 Global pr…

Ophthalmic Grit


I thoroughly enjoy learning about history. At a recent ophthalmology meeting, Richard Mackool, MD, provided a fascinating perspective on 50 years of phacoemulsification. P…

The Literature


Quantitative Optical Coherence Tomography Angiography of Radial Peripapillary Capillaries in Glaucoma, Glaucoma Suspect, and Normal Eyes Mammo Z, Heisler M, Balaratnasi…


GlaucomaToday Polls

View All



Coburn Technologies Introduces New Cobalt Lens Generators, Cobalt NXT and NXT+

Coburn Technologies has introduced its newest lens generators -- the Cobalt NXT & NXT+. The Coba…

Mynosys Cellular Devices Receives $1 Million NEI Grant to Commercialize the Zept…

Mynosys Cellular Devices announced that it has received a SB1 Commercialization Readiness Program (C…

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

About Glaucoma Today

Glaucoma Today is mailed bimonthly (six times a year) to 11,519 glaucoma specialists, general ophthalmologists, and clinical optometrists who treat patients with glaucoma. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, and technology.